Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bijl

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|May 1, 2009
Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophilsN Hu, J Westra, M G Huitema, et al.
Journal of Autoimmunity|November 6, 1998
Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?M Bijl, T van Lopik, P C Limburg, et al.
The Journal of Rheumatology|January 26, 1999
Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapseT van Lopik, M Bijl, M Hart, et al.
Rheumatology (Oxford, England)|January 17, 2002
IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosusM Bijl, H M Dijstelbloem, W W Oost, et al.
The American Journal of Cardiology|January 17, 2016
Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± ChemotherapyJesse M Bijl, Marleen M Roos, Elena M van Leeuwen-Segarceanu, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
A patient with four artificial heart valves after ergotamine therapyM Bijl, T W Galema, L A van Herwerden, et al.
Lupus|September 1, 2012
Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphateC L Overman, A Hartkamp, E R Bossema, et al.
The Netherlands Journal of Medicine|November 29, 2014
Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritisS Arends, J H M Berden, C Grootscholten, et al.
The Journal of Pathology|February 17, 2001
Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosisP Heeringa, M Bijl, A de Jager-Krikken, et al.
Clinical and Experimental Immunology|July 24, 2014
Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?A W S de Souza, W H Abdulahad, P Sosicka, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|May 1, 2009
Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophilsN Hu, J Westra, M G Huitema, et al.
Journal of Autoimmunity|November 6, 1998
Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?M Bijl, T van Lopik, P C Limburg, et al.
The Journal of Rheumatology|January 26, 1999
Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapseT van Lopik, M Bijl, M Hart, et al.
Rheumatology (Oxford, England)|January 17, 2002
IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosusM Bijl, H M Dijstelbloem, W W Oost, et al.
The American Journal of Cardiology|January 17, 2016
Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± ChemotherapyJesse M Bijl, Marleen M Roos, Elena M van Leeuwen-Segarceanu, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
A patient with four artificial heart valves after ergotamine therapyM Bijl, T W Galema, L A van Herwerden, et al.
Lupus|September 1, 2012
Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphateC L Overman, A Hartkamp, E R Bossema, et al.
The Netherlands Journal of Medicine|November 29, 2014
Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritisS Arends, J H M Berden, C Grootscholten, et al.
The Journal of Pathology|February 17, 2001
Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosisP Heeringa, M Bijl, A de Jager-Krikken, et al.
Clinical and Experimental Immunology|July 24, 2014
Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?A W S de Souza, W H Abdulahad, P Sosicka, et al.
Pageof 10